{"api":"v1","generated_at":"2026-10-01T10:20:44.591Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-who-pv-578ae7","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-who-pv-578ae7/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-who-pv-578ae7","canonical_url":"https://api.magentlab.com/api/calc/who_pv","resource":"https://api.magentlab.com/api/calc/who_pv","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"WHO 2016 polycythemia vera criteria (Arber 2016). Met when all three majors hold, or when major 1 and major 2 hold with subnormal EPO. Major 1 is male Hb >16.5 g/dL or Hct >49%, female Hb >16.0 or Hct >48%, or increased red-cell mass. Major 2 is caller-assigned marrow panmyelosis. Major 3 is JAK2 V617F or exon 12. Not a medical device, not a WHO diagnosis, and not WHO 2022. magent does not assay EPO or sequence JAK2.","service_name":"magent","declared_category":null,"declared_tags":["who-2016","pv","hematology","jak2","calculator"],"route_template":null,"registry_updated":"2026-09-28T15:10:14.813Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc who pv","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:10:14.680Z"},"validation":{"latest":{"observed_at":"2026-10-01T07:36:48.209Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-01"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-10-01T07:36:48.209Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T06:54:49.221Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T19:13:20.758Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:56:28.509Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:42:26.242Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["who-2016","pv","hematology","jak2","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/who_pv","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:10:14.68Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/who_pv","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"sex":"male","subnormal_epo":false,"hemoglobin_g_dl":15,"hematocrit_percent":45,"jak2_v617f_or_exon12":false,"bone_marrow_panmyelosis":false,"increased_red_cell_mass":false},{"sex":"male","subnormal_epo":false,"hemoglobin_g_dl":15,"hematocrit_percent":45,"jak2_v617f_or_exon12":false,"bone_marrow_panmyelosis":false,"increased_red_cell_mass":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/who_pv","count":2,"items":[{"sex":"male","minor":false,"formula":"who_pv","major_1":false,"major_2":false,"major_3":false,"citation":{"id":"arber-2016","doi":"10.1182/blood-2016-03-643544","pmid":"27069254","title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","source":"Blood. 2016;127(20):2391-2405","authors":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW"},"criteria":[{"met":false,"factor":"major_1"},{"met":false,"factor":"major_2"},{"met":false,"factor":"major_3"},{"met":false,"factor":"minor"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","subnormal_epo":false,"hemoglobin_g_dl":15,"pv_criteria_met":false,"formula_expression":"pv_criteria_met iff (major_1 and major_2 and major_3) or (major_1 and major_2 and minor); major_1 iff increased_red_cell_mass or (male and (hemoglobin_g_dl > 16.5 or hematocrit_percent > 49)) or (female and (hemoglobin_g_dl > 16.0 or hematocrit_percent > 48)); major_2 bone_marrow_panmyelosis; major_3 jak2_v617f_or_exon12; minor subnormal_epo (Arber 2016 WHO 2016 PV). Not WHO 2022","hematocrit_percent":45,"jak2_v617f_or_exon12":false,"bone_marrow_panmyelosis":false,"increased_red_cell_mass":false},{"sex":"male","minor":false,"formula":"who_pv","major_1":false,"major_2":false,"major_3":false,"citation":{"id":"arber-2016","doi":"10.1182/blood-2016-03-643544","pmid":"27069254","title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","source":"Blood. 2016;127(20):2391-2405","authors":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW"},"criteria":[{"met":false,"factor":"major_1"},{"met":false,"factor":"major_2"},{"met":false,"factor":"major_3"},{"met":false,"factor":"minor"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","subnormal_epo":false,"hemoglobin_g_dl":15,"pv_criteria_met":false,"formula_expression":"pv_criteria_met iff (major_1 and major_2 and major_3) or (major_1 and major_2 and minor); major_1 iff increased_red_cell_mass or (male and (hemoglobin_g_dl > 16.5 or hematocrit_percent > 49)) or (female and (hemoglobin_g_dl > 16.0 or hematocrit_percent > 48)); major_2 bone_marrow_panmyelosis; major_3 jak2_v617f_or_exon12; minor subnormal_epo (Arber 2016 WHO 2016 PV). Not WHO 2022","hematocrit_percent":45,"jak2_v617f_or_exon12":false,"bone_marrow_panmyelosis":false,"increased_red_cell_mass":false}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["sex","increased_red_cell_mass","bone_marrow_panmyelosis","jak2_v617f_or_exon12","subnormal_epo"],"properties":{"sex":{"enum":["female","male"],"type":"string","description":"female or male (Arber 2016 WHO 2016 PV hemoglobin/hematocrit thresholds). Required even when only increased_red_cell_mass is used. Assigned by the caller."},"subnormal_epo":{"type":"boolean","description":"Subnormal serum erythropoietin as assigned by the caller (Arber 2016 WHO 2016 minor criterion). true or false. magent does not assay EPO."},"hemoglobin_g_dl":{"type":"number","description":"Hemoglobin in g/dL (3-22). Major 1 meets when male >16.5 or female >16.0. Optional when hematocrit_percent is sent or increased_red_cell_mass is true. At least one of hemoglobin_g_dl, hematocrit_percent, or increased_red_cell_mass true is required. magent does not assay hemoglobin."},"hematocrit_percent":{"type":"number","description":"Hematocrit percent (10-70). Major 1 meets when male >49 or female >48. Optional when hemoglobin_g_dl is sent or increased_red_cell_mass is true. magent does not assay hematocrit."},"jak2_v617f_or_exon12":{"type":"boolean","description":"JAK2 V617F or JAK2 exon 12 mutation as assigned by the caller (Arber 2016 WHO 2016 major 3). true or false. magent does not sequence JAK2."},"bone_marrow_panmyelosis":{"type":"boolean","description":"WHO 2016 marrow major as assigned by the caller (age-adjusted hypercellularity with panmyelosis, including pleomorphic mature megakaryocytes). true or false. magent does not read slides."},"increased_red_cell_mass":{"type":"boolean","description":"Increased red-cell mass as assigned by the caller (Arber 2016 WHO 2016 major 1 alternative to Hb/Hct). true or false. true meets major 1 even when Hb/Hct are omitted or below threshold. magent does not measure red-cell mass."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"WHO 2016 polycythemia vera criteria (Arber 2016). Met when all three majors hold, or when major 1 and major 2 hold with subnormal EPO. Major 1 is male Hb >16.5 g/dL or Hct >49%, female Hb >16.0 or Hct >48%, or increased red-cell mass. Major 2 is caller-assigned marrow panmyelosis. Major 3 is JAK2 V617F or exon 12. Not a medical device, not a WHO diagnosis, and not WHO 2022. magent does not assay EPO or sequence JAK2.","lastUpdated":"2026-09-28T15:10:14.813Z","serviceName":"magent","x402Version":2}]}}